Why in News:
A Nature Medicine (2025) study reported 54% effectiveness of India’s indigenous Rotavac vaccine against rotavirus gastroenteritis — matching its Phase-3 trial efficacy — under the Universal Immunisation Programme (UIP).
Description:
- Vaccine: Rotavac (developed by Bharat Biotech, India).
- Part of UIP along with: IPV, MR, JE, TB, DPT, Hepatitis B, Hib, etc.
- Already implemented in Himachal Pradesh, Haryana, Odisha, Andhra Pradesh, Assam, Tripura, Rajasthan, Madhya Pradesh, Tamil Nadu.
About Rotavirus:
- Leading cause of severe diarrhoea in children under 5.
- Transmission: Feco-oral route.
- Symptoms: Diarrhoea, vomiting, fever, stomach pain, dehydration.
- Highly contagious; spreads through unwashed hands and contaminated food/water.
WHO Recommendations:
- First dose: After 6 weeks of age, with DTP vaccine.
- Recommended in countries with >10% under-five diarrhoeal mortality.
La Excellence IAS Academy, the best IAS coaching in Hyderabad, known for delivering quality content and conceptual clarity for UPSC 2025 preparation.
FOLLOW US ON:
◉ YouTube : https://www.youtube.com/@CivilsPrepTeam
◉ Facebook: https://www.facebook.com/LaExcellenceIAS
◉ Instagram: https://www.instagram.com/laexcellenceiasacademy/
GET IN TOUCH:
Contact us at info@laex.in, https://laex.in/contact-us/
or Call us @ +91 9052 29 2929, +91 9052 99 2929, +91 9154 24 2140
OUR BRANCHES:
Head Office: H No: 1-10-225A, Beside AEVA Fertility Center, Ashok Nagar Extension, VV Giri Nagar, Ashok Nagar, Hyderabad, 500020
Madhapur: Flat no: 301, survey no 58-60, Guttala begumpet Madhapur metro pillar: 1524, Rangareddy Hyderabad, Telangana 500081
Bangalore: Plot No: 99, 2nd floor, 80 Feet Road, Beside Poorvika Mobiles, Chandra Layout, Attiguppe, Near Vijaya Nagara, Bengaluru, 560040
